Drug Plastics and Glass Co., headquartered in the United States, is a leading manufacturer in the pharmaceutical packaging industry. Founded in 1970, the company has established a strong presence across North America and beyond, specialising in high-quality plastic and glass containers for drug delivery systems. With a commitment to innovation, Drug Plastics offers a diverse range of products, including vials, bottles, and closures, designed to meet the stringent requirements of the healthcare sector. Their unique focus on customisation and compliance with regulatory standards sets them apart in a competitive market. Recognised for their dedication to quality and sustainability, Drug Plastics has achieved significant milestones, solidifying their position as a trusted partner for pharmaceutical companies worldwide.
How does Drug Plastics And Glass Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Rubbe and Plastic Products industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Drug Plastics And Glass Co's score of 15 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Drug Plastics and Glass Co., based in the United States, has not publicly disclosed specific carbon emissions data for the most recent year. However, the company has made significant commitments towards reducing its carbon footprint. Drug Plastics and Glass Co. is committed to achieving net-zero emissions across all scopes by 2050, with a starting point in 2023. This long-term target aligns with the Science Based Targets initiative (SBTi), indicating a structured approach to climate action. The company has set its near-term target status as "Committed," demonstrating its dedication to implementing strategies that will contribute to its overall emissions reduction goals. While specific reduction percentages have not been detailed, the commitment to net-zero emissions reflects an industry-standard approach to addressing climate change within the containers and packaging sector. As Drug Plastics and Glass Co. progresses towards its climate commitments, it will be essential to monitor their initiatives and any future disclosures regarding their carbon emissions and reduction achievements.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Drug Plastics And Glass Co is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.